Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00547456 · ClinicalTrials.gov registry record · NA
Consequences of Nocturnal and Daytime Hypoxemia in COPD
A NA study, sponsored by Northwell Health.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00547456 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 20 participants.
The verdict
NCT00547456, a NA study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
We will determine whether oxygen therapy lowers the level of substances in the blood which cause inflammation, which is one of the adverse effects of COPD and whether oxygen improves overall well being and quality of life as well as sleep quality.
Interventions
- DRUG Oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-10 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00547456
The ClinicalTrials.gov registry entry for NCT00547456 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxygen is the first listed.
NCT00547456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00547456 about?
NCT00547456 is a clinical study titled "Consequences of Nocturnal and Daytime Hypoxemia in COPD". We will determine whether oxygen therapy lowers the level of substances in the blood which cause inflammation, which is one of the adverse effects of COPD and whether oxygen improves overall well being and quality of life as well as sleep quality.
What is the current status of trial NCT00547456?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2005-10. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00547456?
The interventions under investigation include: Oxygen (DRUG).
Who is sponsoring clinical trial NCT00547456?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.